Hospitals have warned that a no deal Brexit could put their pharmacies at increased risk of burglary, as concerns about drug shortages mount.
NHS England will conduct a “rolling tour” of NHS providers to ensure everyone is “geared up” for a possible no-deal Brexit.
A major teaching hospital is putting plans in place to prioritise which patients to treat if a no-deal Brexit causes critical shortages in drugs and/or medical devices.
NHS England has seen off a legal challenge to its largest ever medicines procurement, which is aimed at acquiring drugs to help eliminate hepatitis C in the country by 2025.
The third largest London borough will discontinue its NHS-provided stop smoking service to save money.
Health minister Lord O’Shaughnessy has resigned from his post as Parliamentary under secretary of state in the House of Lords for family reasons.
The prices of certain generic drugs are “seeing another surge” which could have a significant impact on the finances of NHS commissioners, a pharmacy body has warned.
Multiple clinical commissioning groups have raised concerns that patients will start stockpiling medicines and costs will rise if a Brexit deal is not confirmed soon.
A former Department of Health and Social Care permanent secretary has called on the government to put more emphasis on an “innovation rich and technology rich NHS” in order to maintain “a really vibrant life sciences industry” post Brexit.
The government has negotiated a new deal with the pharmaceutical industry which raises the NHS’ cap on spending on branded medicines.
NHS trusts must report annually on how they have dealt with staff concerns over patient safety, under new legislation proposed by the Department of Health and Social Care.
The chief executive of the UK’s medicine regulator is to leave his post in September 2019, six months after the UK is due to leave the European Union.
NHS providers could be asked to stockpile certain types of products under government plans to mitigate the UK leaving the EU without an agreed deal.
A global pharmaceutical company has taken the NHS to court over a procurement process aimed to help England become the first country to eliminate hepatitis C.
Ministers have launched a tender worth “tens of millions” of pounds to provide extra storage capacity in the event of the UK crashing out of the EU without a deal.
NHS providers must submit a business case to show setting up a wholly owned subsidiary company yields value beyond VAT savings, under new proposals from NHS Improvement.
Hundreds of tonnes of human body parts and dangerous waste from NHS patients has been stockpiled by a leading disposal company, sparking a major national incident.
The price of generic drugs could be forced up in the case of a no-deal Brexit, HSJ understands from senior industry sources.
The NHS has today won a landmark legal battle against two international pharmaceutical giants which could save the health service hundreds of millions of pounds a year.
An HSJ roundtable, sponsored by BD, looked at how to reduce medication errors, improving outcomes for patients and reducing waste from unused or unnecessary medicines.
Pharmaceutical industry leaders have warned the government needs to be “fleet of foot” to avoid a significant cost if a no-deal Brexit disrupts approval of generic and biosimilar medicines.
NHS organisations should not spend money on “unnecessary” local stockpiling of medicine ahead of a possible no-deal Brexit.
Drug companies are due to be asked to stockpile up to six weeks of medications ahead of a potential no deal Brexit, HSJ understands.
s 3There are likely to be “serious issues” with the government’s plan to stockpile drugs and medical devices in case of a no-deal Brexit, according to senior figures in the pharmaceutical industry.
Matt Hancock accused the health service of showing a lack of respect for staff and having “very, very old school management which make it far less pleasant than it should be to work in the NHS”.
The government is planning to stockpile drugs for a no-deal Brexit, the health secretary has announced.
NHS England plans to “rapidly expand” the number of medications and treatments it will restrict access to – beyond those which have already been announced or formally proposed.
Former health minister Lord Darzi has been appointed chair of a new innovation panel which will choose which “transformative” medical products should be fast tracked into the NHS.
A health minister said the NHS needs to be better prepared for the budget impact of new medicines such as the oral drug for Hepatitis C, and admitted “we didn’t get it right”.
Twenty organisations have been honoured in the 2018 HSJ Value Awards – which recognise and celebrate outstanding improvements in care quality and efficiency made by NHS staff.